Identification of Cuproptosis-Related Genes in Nonalcoholic Fatty Liver Disease

被引:11
|
作者
Wu C. [1 ]
Liu X. [1 ]
Zhong L. [1 ]
Zhou Y. [1 ,2 ]
Long L. [3 ]
Yi T. [4 ]
Chen S. [1 ]
Li Y. [1 ]
Chen Y. [1 ]
Shen L. [1 ]
Zeng Q. [1 ]
Tang S. [1 ]
机构
[1] Department of Gastroenterology, The First Affiliated Hospital, Jinan University, Guangdong, Guangzhou
[2] Department of Gastroenterology, The First Affiliated Hospital, Gannan Medical University, Ganzhou
[3] Department of Gastroenterology, The Fifth Affiliated Hospital, Guangzhou Medical University, Guangdong, Guangzhou
[4] Department of Oncology, Affiliated Hospital of YouJiang Medical University for Nationalities, Guangxi, Baise
关键词
461.2 Biological Materials and Tissue Engineering - 461.6 Medicine and Pharmacology - 461.9 Biology - 804.1 Organic Compounds - 922.2 Mathematical Statistics;
D O I
10.1155/2023/9245667
中图分类号
学科分类号
摘要
Nonalcoholic fatty liver disease (NAFLD) is the most prevalent hepatic pathology worldwide. However, the precise molecular mechanisms for NAFLD are still not sufficiently explained. Recently, a new mode of cell death (cuproptosis) is found. However, the relationship between NAFLD and cuproptosis remains unclear. We analyzed three public datasets (GSE89632, GSE130970, and GSE135251) to identify cuproptosis-related genes stably expressed in NAFLD. Then, we performed a series of bioinformatics analyses to explore the relationship between NAFLD and cuproptosis-related genes. Finally, 6 high-fat diet- (HFD-) induced NAFLD C57BL/6J mouse models were established to carry out transcriptome analysis. The results of gene set variation analysis (GSVA) revealed that the cuproptosis pathway was abnormally activated to a certain degree (p=0.035 in GSE89632, p=0.016 in GSE130970, p=0.22 in GSE135251), and the principal component analysis (PCA) of the cuproptosis-related genes showed that the NAFLD group separated from the control group, with the first two principal components accounting for 58.63%-74.88% of the variation. Among three datasets, two cuproptosis-related genes (DLD and PDHB, p<0.01 or 0.001) were stably upregulated in NAFLD. Additionally, both DLD (AUC=0.786-0.856) and PDHB (AUC=0.771-0.836) had favorable diagnostic properties, and the multivariate logistics regression model further improved the diagnostic properties (AUC=0.839-0.889). NADH, flavin adenine dinucleotide, and glycine targeted DLD, and pyruvic acid and NADH targeted PDHB in the DrugBank database. The DLD and PDHB were also associated with clinical pathology, especially with steatosis (DLD, p=0.0013-0.025; PDHB, p=0.002-0.0026) and NAFLD activity score (DLD, p=0.004-0.02; PDHB, p=0.003-0.031). What is more, DLD and PDHB were correlated with stromal score (DLD, R=0.38, p<0.001; PDHB, R=0.31, p<0.001) and immune score (DLD, R=0.26, p<0.001; PDHB, R=0.27, p<0.001) in NAFLD. Furthermore, Dld and Pdhb were also significantly upregulated in the NAFLD mouse model. In conclusion, cuproptosis pathways, especially DLD and PDHB, could be potential candidate genes for NAFLD diagnostic and therapeutic options. © 2023 Chutian Wu et al.
引用
收藏
相关论文
共 50 条
  • [21] Identification of Novel Cuproptosis-Related Genes Mediating the Prognosis and Immune Microenvironment in Cholangiocarcinoma
    Liu, Qiang
    Zhu, Jianpeng
    Huang, Zhicheng
    Zhang, Xiaofeng
    Yang, Jianfeng
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2024, 23
  • [22] Identification of cuproptosis-related asthma diagnostic genes by WGCNA analysis and machine learning
    Wang, Fangwei
    Su, Qisheng
    Li, Chaoqian
    JOURNAL OF ASTHMA, 2023, 60 (11) : 2052 - 2063
  • [23] Genetic landscape and clinical significance of cuproptosis-related genes in liver hepatocellular carcinoma
    Hu, Dingtao
    Wang, Yichuan
    Shen, Xu
    Mao, Tiantian
    Liang, Xijun
    Wang, Tengjiao
    Shen, Weifeng
    Zhuang, Yugang
    Ding, Jin
    GENES & DISEASES, 2024, 11 (02) : 516 - 519
  • [24] Cuproptosis and cuproptosis-related genes in rheumatoid arthritis: Implication, prospects, and perspectives
    Zhao, Jianan
    Guo, Shicheng
    Schrodi, Steven J.
    He, Dongyi
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [25] Identification of immune infiltration and cuproptosis-related subgroups in Crohn's disease
    Yuan, Yifan
    Fu, Mingyue
    Li, Na
    Ye, Mei
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [26] The role of cuproptosis-related genes in pan-cancer and the development of cuproptosis-related risk model in colon adenocarcinoma
    Li, Chunwei
    Zhu, Lili
    Liu, Qinghua
    Peng, Mengle
    Deng, Jinhai
    Fan, Zhirui
    Duan, Xiaoran
    Xue, Ruyue
    Guo, Zhiping
    Lv, Xuefeng
    Li, Lifeng
    Zhao, Jie
    HELIYON, 2024, 10 (14)
  • [27] Identification of Variants in Nuclear Lamina-Related Genes in a Cohort of Twins With Nonalcoholic Fatty Liver Disease
    Brady, Graham
    Kwan, Raymond
    Ulintz, Peter
    Loomba, Rohit
    Omary, M. Bishr
    GASTROENTEROLOGY, 2016, 150 (04) : S1020 - S1020
  • [28] Update on nonalcoholic fatty liver disease: genes involved in nonalcoholic fatty liver disease and associated inflammation
    Tilg, Herbert
    Moschen, Alexander
    CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE, 2010, 13 (04): : 391 - 396
  • [29] Cuproptosis and cuproptosis-related genes: Emerging potential therapeutic targets in breast cancer
    Liu, Xiangdong
    Luo, Bo
    Wu, Xinhong
    Tang, Zijian
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2023, 1878 (06):
  • [30] Evaluation the role of cuproptosis-related genes in the pathogenesis, diagnosis and molecular subtypes identification of atherosclerosis
    Wang, Mengxi
    Cheng, Liying
    Xiang, Qian
    Gao, Ziwei
    Ding, Yuhan
    Xie, Haitao
    Chen, Xiaohu
    Yu, Peng
    Shen, Le
    HELIYON, 2023, 9 (10)